| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |